Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

North America Clinical Laboratory Test Companies

North America Clinical laboratory test companies in North America provide a wide range of diagnostic testing services, including medical laboratory tests, pathology services, and other clinical diagnostics. These companies play a crucial role in healthcare by conducting tests to diagnose, monitor, and manage various medical conditions.

North America Clinical Laboratory Test Key CompaniesDisclaimer: List of key companies in no particular orderLatest North America Clinical laboratory test Companies Update

  • July 2023: The Atellica CI Analyzer for immunoassay and clinical chemistry testing, the newest addition to Siemens Healthineers' Atellica in vitro diagnostics range, has acquired FDA clearance and is now accessible in many of the world's major markets. Improved turnaround time predictability, sophisticated reporting features, and laser-focused safety and security precautions are just a few of the ways in which the analyzer gives laboratories with low to medium testing volumes a competitive edge. Due to a lack of qualified workers, laboratories of all sizes have significant difficulties in areas such as ensuring the safety of their employees, keeping their data secure, and meeting their environmental objectives, among many others. It might also be used to determine an individual's likelihood of developing Alzheimer's disease and could be of service to pharmaceutical companies in identifying early-stage patients for inclusion in treatment trials.

    October 2023: For the detection of gene fusions, translocations, and rearrangements across 361 genes in formalin-fixed, paraffin-embedded (FFPE) tumor tissue, AventaTM Genomics, LLC, a clinical laboratory founded as a joint venture between Arima Genomics, Inc. and Protean BioDiagnostics, Inc., launched Aventa FusionPlus in October 2023. CLIA-accredited testing is carried out in Aventa's Florida lab. The Aventa FusionPlus test uses 3D genomics technology, which takes advantage of the fact that fused and rearranged genes are kept in close proximity to one another in order to increase the signal by a factor of 100 to 1000 and to discover previously unknown breakpoints and fusion partners. The Aventa FusionPlus test found potentially actionable variations in 50% of previously described tumor specimens from patients with no known actionable cause.

List of North America Clinical laboratory test Key companies in the market

  • Aurora Diagnostics,

  • Laboratory Corporation of America,

  • LifeLabs Medical Laboratories,

  • Quest Diagnostics

Global North America Clinical Laboratory Test Market Overview

North America Clinical Laboratory Test Market Size was valued at USD 18.2 Billion in 2022. The North America Clinical Laboratory Test market industry is projected to grow from USD 19.54 Billion in 2023 to USD 34.60 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.40% during the forecast period (2023 - 2032). Increased support from the government and a rise in capital expenditure for the development of healthcare facilities are the key market drivers enhancing market growth.

North America Clinical Laboratory Test Market

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

North America Clinical Laboratory Test Market Trends

  • Growing healthcare expenditure is driving the market growth

Market CAGR for North American clinical laboratory test market is being grown due to rising healthcare expenditures. Expanding regulatory backing and increased spending in clinical laboratory tests are expected to propel the market. The economies of North America are sophisticated, and there are strict regulations governing the approval of new tests. The FDA has authorized these experiments in accordance with the 510(k) medical device rule. Panel tests conducted on instruments must go through a similar FDA approval procedure in order to be authorized for commercialization. In Canada, these tests must have approval from Health Canada.

The market is expanding due to the result of favorable regulatory policies and high insurance coverage (almost 100%). If these tests are quickly invoiced to insurance providers, it is simpler for patients to estimate expenses. Urinalysis, blood tests, and screening checks are covered by Medicaid. However, local hospital costs are more expensive than the price of tests.

Obesity and diabetes, which both raise illness risk and lead to metabolic imbalances, are two diseases for which aging has emerged as a prominent risk factor. The demand for clinical laboratory testing is expected to rise as a result. The majority of affluent countries now have life expectancies above 80 years, according to the World Health Organization. Aging is a vital risk factor for the emergence of infectious diseases because it is driven by the connection of numerous environmental and genetic factors that modify immunity, metabolism, and organ functions. Consequently, diagnostics and screening can be quite important in the overall management of health. The market for clinical laboratory testing is being driven by the increase in the worldwide geriatric population as well as the demand for acute and long-term healthcare. Thus, driving the North America Clinical Laboratory Test market revenue.

North America Clinical Laboratory Test Market Segment Insights

North America Clinical Laboratory Test Type of Laboratory Insights

The North America Clinical Laboratory Test market segmentation, based on the type of laboratory includes Hospital-based, Central/Independent, Physician Office Laboratory, and Others. Over the projection period, the segment for central/independent laboratories is anticipated to increase at the quickest rate. The strong market penetration and procedure volumes are credited with the segment's growth. Another significant factor projected to propel the market is the rising number of efforts adopted by governments to offer various services, such as reimbursement for clinical laboratory testing.

North America Clinical Laboratory Test Type of Test Insights

The North America Clinical Laboratory Test market segmentation, based on type of test, includes CBC and Routine Blood Test, Anatomic Pathology, Molecular Test, Immunology Test, Drug Test, and Others. The molecular test category had the biggest revenue share and is anticipated to hold onto the top spot for the duration of the forecast. Additional factors driving the growth of the molecular testing market include the increasing prevalence of lifestyle-related disorders, including diabetes, high blood pressure, also growing public awareness of advanced clinical laboratory tests.

Figure 1 North America Clinical Laboratory Test Market, by Test Type, 2022 & 2032 (USD Billion)

North America Clinical Laboratory Test Market

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

North America Clinical Laboratory Test Regional Insights

By region, the study provides the market insights into North America. The North American North America Clinical Laboratory Test market area will dominate this market, owing to an increase in the count of geriatric population. In addition, the growing spread of chronic diseases like cancer will boost market growth in this region. US held the fastest growth while Canada is expected to register fastest CAGR over the projected period.

The FDA and EMA's regulatory frameworks are extremely important to the US’s healthcare sector. Laboratory-designed tests (LDTs), which are tests developed internally by clinical laboratories that deliver accurate and quick findings, are governed by the Food and Drug Administration (FDA). The mentioned factors are expediting the growth of US Clinical Laboratory Test Market.

The Canada clinical laboratory test Market is expanding as more people become aware of the value of early disease identification and the advantages of early treatment. Some of the government measures that are to blame for the growth of the Canadian clinical diagnostics industry include the federal government's proposed Bill C-17 in the House of Commons, which would grant provinces and territories an additional $2 Bn as a one-time top-up, split evenly by population.

Further, the major countries studied in the market report are The US, and Canada.


North America Clinical Laboratory Test Market

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

North America Clinical Laboratory Test Key Market Players & Competitive Insights

Leading market players are aggressively adopting new business tactics to extend their product offerings, which will help the North America Clinical Laboratory Test market, grow faster. Market participants are also undergoing a range of strategic activities to expand their  presence, with important market developments including new product developments, contracts & agreements, mergers & acquisitions, increased investments, & collaboration with other similar organizations. To expand and survive in a more competitive and rising market climate, North America Clinical Laboratory Test industry must offer cost-effective items.

Manufacturing locally to minimize capital requirements is one of the key business tactics used by manufacturers in the North America Clinical Laboratory Test industry to benefit clients and increase the market sector. In recent years, the North America Clinical Laboratory Test industry has offered some of the most significant advantages to medicine. Major players in the North America Clinical Laboratory Test market, including Aurora Diagnostics, Laboratory Corporation of America, LifeLabs Medical Laboratories, Quest Diagnostics, and others, are attempting to enhance market demand by investing in research and development operations.

Quest Diagnostics Inc. (Quest Diagnostics) offers diagnostic information services to patients and physicians through a network of laboratories and business-owned patient service centers. It provides a variety of services, including anatomic pathology, clinical trial testing, life insurer services, genetic testing, gene-based testing, and other specialized tests, as well as a range of medical information technology and diagnostic devices. Among others, Quest Diagnostics offers its services to hospitals, clinics, managed care organizations, other health insurance companies, laboratories, and governmental organizations. In February 2023, Cleveland Diagnostics, Inc., a biotechnology business in commercial development that creates next-generation diagnostic tests for the early diagnosis of malignancies, today announced a deal intended to increase patient access to the firm's cutting-edge IsoPSA prostate cancer test. Patients will be able to access IsoPSA through an agreement with Quest Diagnostics (NYSE DGX), the country's top provider of diagnostic information services, and, after receiving a prescription from their doctor, provide a blood sample for testing at one of more than 2,100 Quest Diagnostics patient service centre locations nationwide.

Laboratory Corp of America Holdings (LabCorp) offers Clinical laboratory services and complete drug development assistance. It is concentrated on the creation and marketing of various diagnostic technologies and testing services. The business provides clinical diagnostics laboratory services, including standard, genomic, and specialized tests. Forensic identity services, clinical trials services, drug testing services, deoxyribonucleic acid (DNA) identification services, paternity testing services, general and specialty laboratory testing, bone marrow and human leukocyte antigen (HLA) testing, patient services, personalized medicine, and hospital services are just a few of the services it offers. Through Covance, it also provides medication development services. Through a network of primary laboratories and patient care facilities, it provides services to managed care organizations, physicians, hospitals, government agencies, and biotechnology and pharmaceutical businesses. In May 2022, AtlantiCare, the largest healthcare provider in southern New Jersey, and Labcorp (NYSE LH), a top  life sciences firm, announced today that they have completed a transaction to deepen their long-term strategic partnership. Select assets from AtlantiCare's clinical outreach business, which serves the patients of the AtlantiCare Physician Group and Affiliated Physicians throughout southern New Jersey, will be acquired by Labcorp. The deal is the latest in a string of fresh and expanded partnerships between Labcorp and health systems around the nation, highlighting the value Labcorp contributes to enhancing patient care and laboratory services.

Key Companies in the North America Clinical Laboratory Test market include

  • Aurora Diagnostics,

  • Laboratory Corporation of America,

  • LifeLabs Medical Laboratories,

  • Quest Diagnostics

North America Clinical Laboratory Test Industry Developments

May 2021 Neuberg Diagnostics, a company with headquarters in Chennai, stated on Monday that it has begun operating a clinical laboratory in North Carolina, a US state. The NCGM Inc (Neuberg Centre for Genomic Medicine) facility in North Carolina will concentrate on genomic and molecular diagnostics using new generation sequencing technologies.

North America Clinical Laboratory Test Market Segmentation

North America Clinical Laboratory Test, Type of Laboratory Outlook

  • Hospital-based

  • Central/Independent

  • Physician Office Laboratory

  • Others

North America Clinical Laboratory Test, Type of Test Outlook

  • CBC and Routine Blood Test

  • Anatomic Pathology

  • Molecular Test

  • Immunology Test

  • Drug Test

  • Others

North America Clinical Laboratory Test Regional Outlook

  • North America

    • US

    • Canada

  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe

  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific

  • Rest of the World

    • Middle East

    • Africa

    • Latin America

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.